Report cover image

Tranexamic Acid Market Research Report By Formulation Type (Oral Tablets, Injectable Solutions, Topical Applications), By Application (Post-Surgical Bleeding, Menorrhagia, Trauma Cases, Dental Procedures), By Distribution Channel (Hospital Pharmacies, Ret

Publisher Market Research Future
Published Mar 05, 2025
Length 160 Pages
SKU # RESFT19950313

Description

During the study period, the global tranexamic acid market is expected to develop significantly at a compound annual growth rate (CAGR) of 5.38%. By the conclusion of the projection period (2025–2035), the market is anticipated to have grown from its 2024 valuation of USD 1,037.47 million to USD 1,861.99 million.

The growing need for efficient hemostatic agents in pharmaceutical, cosmetic, and medical applications is propelling the global tranexamic acid market's notable expansion. Tranexamic acid is being used more and more in hospitals, clinics, home care, and emergency care settings to stop excessive bleeding after operations, trauma situations, and menstrual disorders. Furthermore, the market is expanding due to rising awareness of tranexamic acid's advantages in dermatology and skincare, especially for the treatment of hyperpigmentation.

Better bioavailability and therapeutic efficacy are made possible by technological developments in drug formulations and delivery systems, which are changing the market environment. Tranexamic acid formulations based on liposomal and nanoparticle technology are among the innovations that are improving therapeutic results while reducing adverse effects. Additionally, the creation of combination treatments that incorporate tranexamic acid with additional active ingredients is broadening the drug's use in both medical and cosmetic applications, which propels market expansion.

An Analysis of Market Segments
According to Formulation Type, the oral segment held a 47.67% market share in 2024 and is anticipated to grow at a compound annual growth rate (CAGR) of 5.83% over the course of the forecast period. Its widespread accessibility, affordability, and ease of use are the main factors driving this. Their substantial market share is a result of the widespread prescription of oral pills for the treatment of ailments including severe menstrual bleeding and surgical bleeding prevention.

According to End User, the hospitals & clinics segment held a 45.25% market share in 2024 and is anticipated to grow at a compound annual growth rate (CAGR) of 5.23% over the course of the forecast period. The increased number of surgical procedures, trauma cases, and critical care treatments that call for tranexamic acid for bleeding control is the reason for this growth.

Analysis by Region
Due to its sophisticated healthcare system, high surgical volume, and growing awareness of blood loss control, North America leads the world market for tranexamic acid (TXA). Because of the growing incidence of trauma-related injuries, the rise in surgical procedures, and the supportive regulatory framework, the United States and Canada have been leading the way in the adoption of TXA.

With robust government backing, extensive clinical uptake, and established pharmaceutical manufacturing capabilities, Europe is a mature and well-regulated TXA market. TXA has been licensed for a number of medicinal applications by the European Medicines Agency (EMA) and national regulatory agencies, guaranteeing uniform use throughout healthcare facilities. The tranexamic acid (TXA) market is growing quickly in countries like Germany and the Asia-Pacific (APAC) region due to factors like rising surgical volumes, high trauma occurrences, growing maternal healthcare concerns, and expanding pharmaceutical output. With increased healthcare spending, increased knowledge of blood loss management, and a growing range of therapeutic applications, nations like China, India, Japan, South Korea, and Australia are leading the way in the adoption of TXA.

Key Players
Among the prominent participants are Ferring Pharmaceuticals, Amring Pharmaceuticals Inc., Aurobindo Pharma, Sun Pharma, Apotex Inc., Teva Pharmaceuticals, Maxwellia Ltd., Pfizer Inc., Fresenius Kabi AG, and Exela Pharma Sciences.

Table of Contents

160 Pages
1 Executive Summary
1.1 Overview
1.2 Market Attractiveness Analysis
1.3 Global Tranexamic Acid Market, By Formulation Type
1.4 Global Tranexamic Acid Market, By Application
1.5 Global Tranexamic Acid Market, By End User
1.6 Global Tranexamic Acid Market, By Region
2 Market Introduction
2.1 Definition
2.2 Scope Of The Study
2.3 Research Objective
2.4 Market Structure
3 Research Methodology
3.1 Overview
3.2 Data Flow
3.2.1 Data Mining Process
3.3 Purchased Database:
3.4 Secondary Sources:
3.4.1 Secondary Research Data Flow:
3.5 Primary Research:
3.5.1 Primary Research Data Flow:
3.5.2 Primary Research: Number Of Interviews Conducted
3.6 Approaches For Market Size Estimation:
3.6.1 Revenue Analysis Approach
3.7 Data Forecasting
3.7.1 Data Forecasting Type
3.8 Data Modeling
3.8.1 Microeconomic Factor Analysis:
3.8.2 Data Modeling:
3.9 Teams And Analyst Contribution
4 Market Dynamics
4.1 Introduction
4.2 Growth Parameters Mapped – Drivers
4.2.1 Increasing Surgical Procedures
4.2.2 Growing Prevalence Of Trauma Cases
4.2.3 Growing Prevalence Of Heavy Menstrual Bleeding (Hmb)
4.3 What Are The Challenges Faced By Industry Participants?
4.3.1 Stringent Regulatory Requirements
4.3.2 High R&D Costs For New Formulations
4.4 Market Opportunities Mapped
4.4.1 Rising Demand For Minimally Invasive & Non-surgical Treatment Options
4.4.2 Untapped Potential In Emerging Markets
5 Market Factor Analysis
5.1 Porter’s Five Forces Model
5.1.1 Bargaining Power Of Suppliers
5.1.2 Bargaining Power Of Buyers
5.1.3 Threat Of New Entrants
5.1.4 Threat Of Substitutes
5.1.5 Intensity Of Rivalry
5.2 Covid-19 Impact Analysis
5.2.1 Impact On R & D
5.2.2 Impact On Supply Chain
5.2.3 Impact On Pricing
6 Global Tranexamic Acid Market, By Formulation Type
6.1 Introduction
6.2 Oral
6.3 Injectable
6.4 Tropical
7 Global Tranexamic Acid Market, By Application
7.1 Introduction
7.2 Menorrhagia
7.3 Surgical Bleeding Control
7.4 Trauma And Injury
7.5 Hereditary Angioedema (Hae)
7.6 Postpartum Hemorrhage
7.7 Others
8 Global Tranexamic Acid Market, By End User
8.1 Introduction
8.2 Hospitals & Clinics
8.3 Ambulatory Surgical Centers
8.4 Others
9 Global Tranexamic Acid Market, By Region
9.1 Overview
9.2 North America
9.2.1 Us
9.2.2 Canada
9.3 Europe
9.3.1 Germany
9.3.2 Uk
9.3.3 France
9.3.4 Italy
9.3.5 Spain
9.3.6 Rest Of Europe
9.4 Asia-pacific
9.4.1 China
9.4.2 India
9.4.3 Japan
9.4.4 South Korea
9.4.5 Australia
9.4.6 Rest Of Asia-pacific
9.5 Rest Of The World
9.5.1 Middle East
9.5.2 Africa
9.5.3 Latin America
10 Competitive Landscape
10.1 Introduction
10.2 Market Share Analysis, 2024
10.3 Competition Dashboard
10.3.1 Product Portfolio
10.3.2 Regional Presence
10.3.3 Strategic Alliances
10.3.4 Industry Experiences
10.4 Who Are The Major Disruptors & Innovators
10.5 What Strategies Are Being Adopted By Market Leaders
10.6 Key Developments & Growth Strategies
10.6.1 Merger And Acquisition
10.6.2 Product Launch
11 Company Profiles
11.1 Pfizer Inc
11.1.1 Company Overview
11.1.2 Financial Overview
11.1.3 Products Offered
11.1.4 Key Developments
11.1.5 Swot Analysis
11.1.6 Key Strategy
11.2 Fresenius Kabi Usa, Llc
11.2.1 Company Overview
11.2.2 Financial Overview
11.2.3 Products Offered
11.2.4 Key Developments
11.2.5 Swot Analysis
11.2.6 Key Strategy
11.3 Teva Pharmaceutical Industries Ltd.
11.3.1 Company Overview
11.3.2 Financial Overview
11.3.3 Products Offered
11.3.4 Key Developments
11.3.5 Swot Analysis
11.3.6 Key Strategy
11.4 Maxwellia Ltd.
11.4.1 Company Overview
11.4.2 Products Offered
11.4.3 Key Developments
11.4.4 Swot Analysis
11.4.5 Key Strategy
11.5 Aurobindo Pharma Usa
11.5.1 Company Overview
11.5.2 Products Offered
11.5.3 Key Developments
11.5.4 Swot Analysis
11.5.5 Key Strategy
11.6 Sun Pharmaceutical Industries Ltd.
11.6.1 Company Overview
11.6.2 Financial Overview
11.6.3 Products Offered
11.6.4 Key Developments
11.6.5 Swot Analysis
11.6.6 Key Strategy
11.7 Apotex Inc.
11.7.1 Company Overview
11.7.2 Products Offered
11.7.3 Key Developments
11.7.4 Swot Analysis
11.7.5 Key Strategy
11.8 Ferring Pharmaceuticals
11.8.1 Company Overview
11.8.2 Products Offered
11.8.3 Key Developments
11.8.4 Swot Analysis
11.8.5 Key Strategy
11.9 Nordic Pharma, Inc
11.9.1 Company Overview
11.9.2 Products Offered
11.9.3 Key Developments
11.9.4 Swot Analysis
11.9.5 Key Strategy
11.10 Exela Pharma Sciences Llc
11.10.1 Company Overview
11.10.2 Products Offered
11.10.3 Key Developments
11.10.4 Swot Analysis
11.10.5 Key Strategy
12 Data Citations
Table 1 Qfd Modeling For Market Share Assessment
Table 2 Global Tranexamic Acid Market, By Formulation Type, 2019–2035 (Usd Million)
Table 3 Global Tranexamic Acid Market, For Oral, By Region, 2019–2035 (Usd Million)
Table 4 Global Tranexamic Acid Market, For Injectable, By Region, 2019–2035 (Usd Million)
Table 5 Global Tranexamic Acid Market, For Tropical, By Region, 2019–2035 (Usd Million)
Table 6 Global Tranexamic Acid Market, By Application, 2019–2035 (Usd Million)
Table 7 Global Tranexamic Acid Market, For Menorrhagia, By Region, 2019–2035 (Usd Million)
Table 8 Global Tranexamic Acid Market, For Surgical Bleeding Control, By Region, 2019–2035 (Usd Million)
Table 9 Global Tranexamic Acid Market, For Trauma And Injury, By Region, 2019–2035 (Usd Million)
Table 10 Global Tranexamic Acid Market, For Hereditary Angioedema (Hae), By Region, 2019–2035 (Usd Million)
Table 11 Global Tranexamic Acid Market, For Postpartum Hemorrhage, By Region, 2019–2035 (Usd Million)
Table 12 Global Tranexamic Acid Market, For Others, By Region, 2019–2035 (Usd Million)
Table 13 Global Tranexamic Acid Market, By End User, 2019–2035 (Usd Million)
Table 14 Global Tranexamic Acid Market, For Hospitals & Clinics, By Region, 2019–2035 (Usd Million)
Table 15 Global Tranexamic Acid Market, For Ambulatory Surgical Centers, By Region, 2019–2035 (Usd Million)
Table 16 Global Tranexamic Acid Market, For Others, By Region, 2019–2035 (Usd Million)
Table 17 Global Tranexamic Acid Market, By Region, 2019-2035 (Usd Million)
Table 18 North America Tranexamic Acids Market, By Country, 2019–2035 (Usd Million)
Table 19 North America: Tranexamic Acid Market, By Formulation Type, 2019–2035 (Usd Million)
Table 20 North America: Tranexamic Acid Market, By Application, 2019–2035 (Usd Million)
Table 21 North America: Tranexamic Acid Market, By End User, 2019–2035 (Usd Million)
Table 22 Us: Tranexamic Acid Market, By Formulation Type, 2019–2035 (Usd Million)
Table 23 Us: Tranexamic Acid Market, By Application, 2019–2035 (Usd Million)
Table 24 Us: Tranexamic Acid Market, By End User, 2019–2035 (Usd Million)
Table 25 Canada: Tranexamic Acid Market, By Formulation Type, 2019–2035 (Usd Million)
Table 26 Canada: Tranexamic Acid Market, By Application, 2019–2035 (Usd Million)
Table 27 Canada: Tranexamic Acid Market, By End User, 2019–2035 (Usd Million)
Table 28 Europe: Tranexamic Acids Market, By Country, 2019–2035 (Usd Million)
Table 29 Europe: Tranexamic Acid Market, By Formulation Type, 2019–2035 (Usd Million)
Table 30 Europe: Tranexamic Acid Market, By Application, 2019–2035 (Usd Million)
Table 31 Europe: Tranexamic Acid Market, By End User, 2019–2035 (Usd Million)
Table 32 Germany: Tranexamic Acid Market, By Formulation Type, 2019–2035 (Usd Million)
Table 33 Germany: Tranexamic Acid Market, By Application, 2019–2035 (Usd Million)
Table 34 Germany: Tranexamic Acid Market, By End User, 2019–2035 (Usd Million)
Table 35 Uk: Tranexamic Acid Market, By Formulation Type, 2019–2035 (Usd Million)
Table 36 Uk: Tranexamic Acid Market, By Application, 2019–2035 (Usd Million)
Table 37 Uk: Tranexamic Acid Market, By End User, 2019–2035 (Usd Million)
Table 38 France: Tranexamic Acid Market, By Formulation Type, 2019–2035 (Usd Million)
Table 39 France: Tranexamic Acid Market, By Application, 2019–2035 (Usd Million)
Table 40 France: Tranexamic Acid Market, By End User, 2019–2035 (Usd Million)
Table 41 Italy: Tranexamic Acid Market, By Formulation Type, 2019–2035 (Usd Million)
Table 42 Italy: Tranexamic Acid Market, By Application, 2019–2035 (Usd Million)
Table 43 Italy: Tranexamic Acid Market, By End User, 2019–2035 (Usd Million)
Table 44 Spain: Tranexamic Acid Market, By Formulation Type, 2019–2035 (Usd Million)
Table 45 Spain: Tranexamic Acid Market, By Application, 2019–2035 (Usd Million)
Table 46 Spain: Tranexamic Acid Market, By End User, 2019–2035 (Usd Million)
Table 47 Rest Of Europe: Tranexamic Acid Market, By Formulation Type, 2019–2035 (Usd Million)
Table 48 Rest Of Europe: Tranexamic Acid Market, By Application, 2019–2035 (Usd Million)
Table 49 Rest Of Europe: Tranexamic Acid Market, By End User, 2019–2035 (Usd Million)
List Of Figures
Figure 1 Market Attractiveness Analysis: Global Tranexamic Acid Market, 2024
Figure 2 Global Tranexamic Acid Market Analysis, By Formulation Type, 2024
Figure 3 Global Tranexamic Acid Analysis, By Application, 2024
Figure 4 Global Tranexamic Acid Analysis, By End User, 2024
Figure 5 Global Tranexamic Acid Market Analysis, By Region, 2024
Figure 1 Global Tranexamic Acid Market: Structure
Figure 2 Global Tranexamic Acid Market: Market Growth Factor Analysis (2019-2035)
Figure 3 Driver Impact Analysis (2019-2035)
Figure 4 Porter’s Five Forces Model: Global Tranexamic Acid Market
Figure 5 Global Tranexamic Acid Market, By Formulation Type, Segment Attractiveness Analysis
Figure 6 Global Tranexamic Acid Market, By Formulation Type, 2024 & 2035 (Usd Million)
Figure 7 Global Tranexamic Acid Market Share (%), By Formulation Type, 2024
Figure 8 Global Tranexamic Acid Market, By Application, Segment Attractiveness Analysis
Figure 9 Global Tranexamic Acid Market, By Application, 2024 & 2035 (Usd Million)
Figure 10 Global Tranexamic Acid Market Share (%), By Application, 2024
Figure 11 Global Tranexamic Acid Market, By End User, Segment Attractiveness Analysis
Figure 12 Global Tranexamic Acid Market, By End User, 2024 & 2035 (Usd Million)
Figure 13 Global Tranexamic Acid Market Share (%), By End User, 2024
Figure 14 Global Tranexamic Acid Market, By Region, 2024 & 2035 (Usd Million)
Figure 15 Global Tranexamic Acid Market Share (%), By Region, 2024
Figure 16 North America: Tranexamic Acid Market, By Country, 2024 & 2035 (Usd Million)
Figure 17 North America: Tranexamic Acid Market Share (%), By Country, 2024
Figure 18 Europe: Tranexamic Acids Market Share, By Country, 2024 & 2035 (Usd Million)
Figure 19 Europe: Tranexamic Acids Market Share, By Country, 2024 (%)
Figure 20 Asia-pacific: Tranexamic Acid Market Share, By Country, 2024 & 2035 (Usd Million)
Figure 21 Asia-pacific: Tranexamic Acid Market Share, By Country, 2024 (%)
Figure 22 Rest Of The World: Tranexamic Acid Market Share, By Country, 2024 & 2035 (Usd Million)
Figure 23 Rest Of The World: Tranexamic Acid Market Share, By Region, 2024 (%)
Figure 24 Global Tranexamic Acid Market Players: Competitive Analysis, 2024
Figure 25 Competitor Dashboard: Global Tranexamic Acid Market
Figure 26 Pfizer Inc: Swot Analysis
Figure 27 Fresenius Kabi Usa, Llc: Swot Analysis
Figure 28 Teva Pharmaceutical Industries Ltd: Swot Analysis
Figure 29 Maxwellia Ltd: Swot Analysis
Figure 30 Aurobindo Pharma Usa: Swot Analysis
Figure 31 Sun Pharmaceutical Industries Ltd.: Swot Analysis
Figure 32 Apotex Inc.: Swot Analysis
Figure 33 Ferring Pharmaceuticals: Swot Analysis
Figure 34 Nordic Pharma, Inc: Swot Analysis
Figure 35 Exela Pharma Sciences Llc: Swot Analysis

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us